SATB2 participates in regulation of menadione-induced apoptotic insults to osteoblasts

Journal of Orthopaedic Research

Volumn 30, Issue 7, 2012, Pages 1058-1066

  Wei, Jyh Ding ^a,b   Lin, Yi Ling ^b   Tsai, Cheng Hsiu ^c   Shieh, Hui Shan ^c   Lin, Pei I ^c   Ho, Wei Pin ^b   Chen, Ruei Ming ^b,c  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

apoptosis; menadione; mitochondria; osteoblasts; SATB2

Indexed keywords

CASPASE 3; DNA BINDING PROTEIN; MENADIONE; MESSENGER RNA; SMALL INTERFERING RNA; SPECIAL ADENINE THYMINE RICH SEQUENCE BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVITY; GENE SILENCING; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; RNA TRANSLATION;

EID: 84861094513     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22046     Document Type: Article

References (39)

1. Partridge NC, Alcorn D, Michelangeli VP, et al. 1981. Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells. Endocrinology 108: 213-219.
2. Takeda S, Karsenty G,. 2001. Central control of bone formation. J Bone Miner Metab 19: 195-198.
3. Engin F, Lee B,. 2010. NOTCHing the bone: Insights into multi-functionality. Bone 46: 274-280.
4. L gene expression. J Bone Miner Res 25: 2193-2204.
5. Evans DM, Ralston SH,. 1996. Nitric oxide and bone. J Bone Miner Res 11: 300-305.
6. Bai XC, Lu D, Liu AL, et al. 2005. Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblasts. J Biol Chem 280: 17497-17506.
7. Armour KE, Van'T Hof FJ, Grabowski PS, et al. 1999. Evidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis. J Bone Miner Res 14: 2137-2142.
8. Chen RM, Liu HC, Lin YL, et al. 2002. Nitric oxide induces osteoblast apoptosis through the de novo synthesis of Bax protein. J Orthop Res 20: 295-302.
9. L expression. Chem Biol Interact 184: 359-365.
10. Ho WP, Chan WP, Hsieh MS, et al. 2009. Runx2-mediated Bcl-2 gene expression contributes to nitric oxide protection against oxidative stress-induced osteoblast apoptosis. J Cell Biochem 108: 1084-1093.
11. Dobreva G, Dambacher J, Grosschedl R,. 2003. SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. Genes Dev 17: 3048-3061.
12. FitzPatrick DR, Carr IM, McLaren L, et al. 2003. Identification of SATB2 as the cleft palate gene on 2q32-q33. Hum Mol Genet 12: 2491-2501.
13. Ellies DL, Krumlauf R,. 2006. Bone formation: The nuclear matrix reloaded. Cell 125: 840-842.
14. Leone DP, Srinivasan K, Chen B, et al. 2008. The determination of projection neuron identity in the developing cerebral cortex. Curr Opin Neurobiol 18: 28-35.
15. Szemes M, Gyorgy A, Paweletz C, et al. 2006. Isolation and characterization of SATB2, a novel AT-rich DNA binding protein expressed in development- and cell-specific manner in the rat brain. Neurochem Res 31: 237-246.
16. Dobreva G, Chahrour M, Dautzenberg M, et al. 2006. SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 125: 971-986.
17. Hassan MQ, Gordon JA, Beloti MM, et al. 2010. A network connecting Runx2, SATB2, and the miR-23â27â24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci USA 107: 19879-19884.
18. Chung J, Lau J, Cheng LS, et al. 2010. SATB2 augments Î"Np63α in head and neck squamous cell carcinoma. EMBO Rep 11: 777-783.
19. Hock JM, Krishnan V, Onyia JE, et al. 2001. Osteoblast apoptosis and bone turnover. J Bone Miner Res 16: 975-984.
20. Rojas E, Carlini RG, Clesca P, et al. 2003. The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling. Kidney Int 63: 1915-1923.
21. Vandenabeele P, Galluzzi L, Vanden Berghe T, et al. 2010. Molecular mechanisms of necroptosis: An ordered cellular explosion. Nat Rev Mol Cell Biol 11: 700-714.
22. Kim JJ, Lee SB, Park JK, et al. 2010. TNF-alpha-induced ROS production triggering apoptosis is directly linked to Romo1 and Bcl-X(L). Cell Death Differ 17: 1420-1434.
23. Chang CC, Liao YS, Lin YL, et al. 2006. Nitric oxide protects osteoblasts from oxidative stress-induced apoptotic insults via a mitochondria-dependent mechanism. J Orthop Res 24: 1917-1925.
24. Tai YT, Cherng YG, Chang CC, et al. 2007. Pretreatment with low nitric oxide protects osteoblasts from high nitric oxide-induced apoptotic insults through regulation of c-Jun N-terminal kinase/c-Jun-mediated Bcl-2 gene expression and protein translocation. J Orthop Res 25: 625-635.
25. Sun JS, Tsuang YH, Huang WC, et al. 1997. Menadione-induced cytotoxicity to rat osteoblasts. Cell Mol Life Sci 53: 967-976.
26. Huang TY, Chen TL, Liao MH, et al. 2010. Drynaria fortunei J. Sm. promotes osteoblast maturation by inducing differentiation-related gene expression and protecting against oxidative stress-induced apoptotic insults. J Ethnopharmacol 131: 70-77.
27. Lin YL, Chang HC, Chen TL, et al. 2011. Resveratrol protects against oxidized LDL-induced breakage of the blood-brain barrier by lessening disruption of tight junctions and apoptotic insults to mouse cerebrovascular endothelial cells. J Nutr 140: 2187-2192.
28. Lee ST, Wu TT, Yu PY, et al. 2009. Apoptotic insults to human HepG2cells induced by S-(+)-ketamine occurs through activation of a Bax-mitochondria- caspase protease pathway. Br J Anaesth 102: 80-89.
29. Chang HC, Chen TG, Tai YT, et al. 2011. Resveratrol attenuates oxidized LDL-evoked Lox-1 signaling and consequently protects against apoptotic insults to cerebrovascular endothelial cells. J Cereb Blood Flow Metab 31: 842-854.
30. Yadav SS, Sindram D, Perry DK, et al. 1999. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology 30: 1223-1231.
31. Wu GJ, Chen TL, Ueng YF, et al. 2008. Ketamine inhibits tumor necrosis factor-α and interleukin-6 gene expressions in lipopolysaccharide- stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation. Toxicol Appl Pharmacol 228: 105-113.
32. Chang HC, Chen TL, Chen RM,. 2009. Cytoskeleton interruption in human hepatoma HepG2cells induced by ketamine occurs possibly through suppression of calcium mobilization and mitochondrial function. Drug Metab Dispos 37: 24-31.
33. Murray AB, Schulze H, Blauw E,. 1991. In situ embedding of cell monolayers cultured on plastic surfaces for electron microscopy. Biotech Histochem 66: 269-272.
34. Britanova O, Depew MJ, Schwark M, et al. 2006. Satb2 haploinsufficiency phenocopies 2q32-q33 deletions, whereas loss suggests a fundamental role in the coordination of jaw development. Am J Hum Genet 79: 668-678.
35. Beloqui O, Cederbaum AI,. 1986. Microsomal interactions between iron, paraquat, and menadione: Effect on hydroxyl radical production and alcohol oxidation. Arch Biochem Biophys 242: 187-196.
36. Hou Q, Hsu YT,. 2005. Bax translocates from cytosol to mitochondria in cardiac cells during apoptosis: Development of a GFP-Bax-stable H9c2 cell line for apoptosis analysis. Am J Physiol Heart Circ Physiol 289: H477-H487.
37. Saelens X, Festjens N, Vande Walle L, et al. 2004. Toxic proteins released from mitochondria in cell death. Oncogene 23: 2861-2874.
38. Yu VW, Akhouayri O, St-Arnaud R,. 2009. FIAT is co-expressed with its dimerization target ATF4 in early osteoblasts, but not in osteocytes. Gene Expr Patterns 9: 335-340.
39. Hinoi E, Takarada T, Tsuchihashi Y, et al. 2006. A molecular mechanism of pyruvate protection against cytotoxicity of reactive oxygen species in osteoblasts. Mol Pharmacol 70: 925-935.